Blood News and Research

RSS

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduced the risk of cardiovascular death, heart attack or stroke within 30 days following the procedure, according to an article in the September 14 issue of JAMA: The Journal of the American Medical Association.

5 Sep 2005

Researchers discover one of the reasons why melanoma is so ruthless

About 60,000 Americans will be diagnosed with melanoma this year, says the American Cancer Society, and 10,000 of those cases will be fatal. If not caught in the early stages, melanoma can be a particularly virulent form of cancer, spreading through the body with an efficiency that few tumors possess.

5 Sep 2005

World's largest study on acute coronary syndromes

A Canadian-led study involving researchers from 41 countries has demonstrated in the world's largest study of acute coronary syndromes (ACS) that a new anti-thrombotic therapy is safer and as effective as the traditional therapy used in preventing heart attacks, death and ischemia in people with serious heart conditions.

5 Sep 2005

New blood pressure-lowering drugs reduce stroke risk by 50%

According to researchers the new types of blood pressure-lowering drugs are more effective in preventing strokes and heart attacks and save even more lives.

5 Sep 2005

New key evidence supports claims that some types of cancer originate with defects in stem cells

Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Científic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells.

4 Sep 2005

Medication before angiograph significantly reduces risk of heart attack

According to new research if patients are given the a drug which reduces platelet activity in the blood risk of heart attack and cardiovascular death before and after angioplasty is reduced.

4 Sep 2005

Naturally occurring peptide hormones - candidates for the treatment of cancer, sexual dysfunction, eating disorders

Chemists at the University of Arizona have developed modified versions of naturally occurring peptide hormones that could be key to novel treatments of a variety of diseases, including eating disorders (anorexia, obesity), diabetes, sexual dysfunction and skin cancer.

1 Sep 2005

Potential new way to fight HIV

Researchers have confirmed for the first time the benefit of an innate defense system present in the few patients who remain healthy after years of infection with HIV despite receiving no treatment, according to an article published in the September edition of the Journal of Virology.

1 Sep 2005

Can a new combination treatment prevent a secondary stroke in children with sickle cell anemia?

St. Jude Children’s Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.

1 Sep 2005

Been there, done that!

One of the neural oddities of "declarative" memory--the recall of past things and events--is that some experiments have shown that recognizing a familiar object is accompanied by a reduction in activity of the brain's memory centers in the medial temporal lobe. Such a reduction seems counterintuitive, since remembering seems to be a positive event.

1 Sep 2005

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Mayo Clinic Cancer Center investigators report that combination therapy with lenalidomide (Revlimid) and dexamethasone (combination is called Rev/Dex) looks like a breakthrough treatment for multiple myeloma. Results of a Phase II clinical trial were published online Aug. 23 in Blood.

1 Sep 2005

Legs For Life free national screening program can save legs

The screening is essential for diabetics in order to prevent amputation, heart attack and stroke, because one-third have PAD, but most do not present classic symptoms.

1 Sep 2005

Complex chemotherapy cocktails offers pluses, minuses in advanced endometrial cancer

Complex chemotherapy cocktails offer about one extra month of life to patients with end-stage endometrial cancer but also can result in severe, possibly fatal, side effects, according to the first systematic review of studies addressing the topic.

1 Sep 2005

Study provides first steps toward individualized treatment of serious injuries

A multi-institutional research collaborative has begun to decipher the complex interplay of genes that underlies the body's response to major injuries.

1 Sep 2005

Deadly health crisis imminent in New Orleans

In New Orleans, as a result of hurricane Katrina, health specialists are predicting a vast and potentially deadly crisis for residents.

1 Sep 2005

Unrecognized hypertension is common among emergency room patients, especially African Americans

Half of the study participants with high blood pressure reported that they were not under medical care for the condition. Further, the majority of this group stated that they had never been told that they had high blood pressure.

1 Sep 2005

People with serious mental illness have higher rates of type 2 diabetes

...yet their knowledge of diabetes was generally poor and significantly lower than people without mental illness, according to a new study.

1 Sep 2005

MRSA risk doubled in critically ill patients with glucose in their airways

Critically ill patients with glucose in their airways seem to be at double the risk of picking up serious hospital acquired infections, including MRSA, suggests research in Thorax.

1 Sep 2005

More than 15 percent of our genes are mobilized to defend against microbial attacks

The body's overwhelming genetic defense, which has implications for the survival of patients who are severely burned or injured, was revealed in a sweeping analysis of gene activity in volunteers who were injected with a bacterial product that temporarily created flu-like symptoms.

1 Sep 2005

Study suggests cirrhosis and liver disease nearly inevitable for people with hep C

Nearly 80 percent of chronic hepatitis C sufferers who have the disease for several decades will develop cirrhosis or end-stage liver disease later in life, according to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology.

1 Sep 2005

Blood News and Research

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

Researchers discover one of the reasons why melanoma is so ruthless

World's largest study on acute coronary syndromes

New blood pressure-lowering drugs reduce stroke risk by 50%

New key evidence supports claims that some types of cancer originate with defects in stem cells

Medication before angiograph significantly reduces risk of heart attack

Naturally occurring peptide hormones - candidates for the treatment of cancer, sexual dysfunction, eating disorders

Potential new way to fight HIV

Can a new combination treatment prevent a secondary stroke in children with sickle cell anemia?

Been there, done that!

Rev/Dex combo looks like a breakthrough treatment for multiple myeloma

Legs For Life free national screening program can save legs

Complex chemotherapy cocktails offers pluses, minuses in advanced endometrial cancer

Study provides first steps toward individualized treatment of serious injuries

Deadly health crisis imminent in New Orleans

Unrecognized hypertension is common among emergency room patients, especially African Americans

People with serious mental illness have higher rates of type 2 diabetes

MRSA risk doubled in critically ill patients with glucose in their airways

More than 15 percent of our genes are mobilized to defend against microbial attacks

Study suggests cirrhosis and liver disease nearly inevitable for people with hep C

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News